Chromothripsis: One Catastrophe, Many Rearrangements

How the Shattering Happens

A leading model is that a lagging chromosome is trapped in a micronucleus, where DNA replication and repair are defective. The chromosome is pulverised and then rejoined by error-prone end-joining, producing tens to hundreds of rearrangements confined to that chromosome.

A related route involves breakage-fusion-bridge cycles at unprotected chromosome ends, which can feed into the same scrambled outcome and into circular extrachromosomal DNA.

How It Is Recognised

In whole-genome sequencing, chromothripsis appears as many breakpoints clustered on one or a few chromosomes, copy-number states oscillating between just two levels, and preservation of heterozygosity in retained segments. These criteria distinguish it from gradual, stepwise rearrangement.

Targeted panels usually cannot detect it because they do not survey enough of the genome to see the breakpoint pattern.

Why It Matters

Because it can simultaneously amplify an oncogene and delete tumour suppressors, chromothripsis provides a mechanism for rapid, punctuated tumour evolution rather than slow accumulation of single mutations.

It has been linked to aggressive behaviour in several cancers and to the generation of extrachromosomal DNA that carries oncogene amplifications and drives drug resistance. Its presence is descriptive of tumour genome architecture, not a standalone treatment biomarker.

Chromothripsis and Extrachromosomal DNA

One reason chromothripsis has drawn renewed attention is its role in generating extrachromosomal DNA: small circular fragments that carry oncogene amplifications, replicate independently, and segregate unequally at cell division. This lets a tumour rapidly raise or lower oncogene copy number under treatment pressure, a flexible form of resistance.

For a report, a note of chromothripsis or of extrachromosomal-DNA-like focal amplification is context about how the genome is behaving. It is not yet a biomarker that selects a drug, though extrachromosomal-DNA-directed strategies are an active area of drug development.

Key Takeaways

• ·Chromothripsis is a single-event shattering and faulty reassembly of one or a few chromosomes.
• ·It is identified by clustered breakpoints and oscillating two-state copy number in whole-genome data.
• ·It enables rapid, punctuated genome change and can seed oncogene-carrying extrachromosomal DNA.